Sign In | Join Free | My
Wuhan uni-pharma bio-tech co.,ltd
Wuhan Uni-pharma Bio-tech Co.,Ltd
Home > Sterile Powder For Injection >

40mg Sterile Powder For Injection Methylprednisolone Sodium Succinate Injection I.M. / I.V. Use

Wuhan uni-pharma bio-tech co.,ltd
Wuhan uni-pharma bio-tech co.,ltd
Province/State: Hubei
Country/Region: China
Tel: 86-27-82316816

40mg Sterile Powder For Injection Methylprednisolone Sodium Succinate Injection I.M. / I.V. Use

Brand Name : Uni-pharma
Model Number : 40mg
Certification : GMP
Place of Origin : China
MOQ : 600000Vials
Price : USD 0.65/Box
Payment Terms : L/C, D/A, D/P, T/T, Western Union
Delivery Time : After packaging confirmed 30 days
Packaging Details : 1 vial + 1 solvent/Box 400 Boxes/Carton Carton Size: 47x30x31.5cm
Applications : Internal Medicine
Usage method : Injectable
Applicable people : Adults/Children
Form : Solid
Shape : Powder
Type : Organic Chemcials
Pharmaceutical methods : Chemical Synthesis
Specification : 40mg
Contact Now

Western Medicine Methylperdnisolone sodium succinat for injection 40mg Sterile Powder (For I.M./I.V.)


This product is the main ingredients of methylprednisolone sodium succinate, chemical name: 11 beta, alpha 17, alpha 21- three hydroxy -6 methyl pregnane -1, 4- diene -3, 20- two -21- sodium succinate ketone.

Chemical structure:

Molecular formula: C26H33O8Na

Molecular weight: 496.53

Accessories: two sodium bicarbonate, sodium dihydrogen phosphate, sodium hydrogen phosphate.

1. Anti-inflammatory treatment:

(rheumatic disease: as a short-term adjunct) (to help patients pass through acute or critical periods):

Posttraumatic osteoarthritis; synovitis caused by osteoarthritis; rheumatoid arthritis, juvenile rheumatoid arthritis (individual patients may need low dose maintenance treatment); acute or subacute bursitis; ankle arthritis; acute nonspecific tendon sheath inflammation; acute gouty arthritis; psoriatic arthritis; ankylosing spondylitis.

Collagen disorder (immune complex disease): critical illness or maintenance therapy for the following diseases:

Systemic lupus erythematosus (lupus nephritis); acute rheumatic myocarditis; systemic dermatomyositis (PM); polyarteritis nodosa; Goodpasture syndrome (Good pasture 's Syndrome). Skin disease: pemphigus; severe erythema multiforme (Stevens-Johnson syndrome); exfoliative dermatitis; bullous dermatitis herpetiformis; severe seborrheic dermatitis; severe psoriasis; mycosis fungoides; urticaria.

Allergy status: used to control the following to conventional treatment to deal with the serious damage caused by function or allergic diseases; bronchial asthma; contact dermatitis; atopic dermatitis; serum sickness; seasonal or perennial allergic rhinitis; allergic reaction; urticarial transfusion reaction; edema of acute non infective throat (epinephrine is the drug of choice).

- eye disease: severe acute and chronic ocular allergy and inflammation, such as herpes zoster; iritis, iridocyclitis; chorioretinitis; diffusion type real uveitis and choroiditis; optic neuritis; sympathetic ophthalmia.

Gastrointestinal disease: a critical period for patients to survive the following diseases; ulcerative colitis (systemic therapy); localized enterocolitis (systemic therapy). Respiratory disease: pulmonary sarcoidosis; beryllium poisoning;

Combined with appropriate anti tuberculosis chemotherapy for fulminant or diffuse tuberculosis;

Other methods cannot control Loeffler's syndrome (Loffler s Syndrome); aspiration pneumonia.

Edema: diuretic and urinary proteinuria for spontaneous or lupus nephrotic syndrome without uremia.

2. Immunosuppressive therapy:organ transplantation.
3, The treatment of blood diseases and tumors:

- blood diseases: acquired (autoimmune hemolytic anemia); adult idiopathic thrombocytopenic purpura (only intravenous injection, intramuscular injection of taboo); adult secondary thrombocytopenia; erythroblastopenia (anemia); congenital (red blood cell) aplastic anemia.

Tumor: palliative care for the following diseases; adult leukemia and lymphoma; childhood acute leukemia

4, Treatment shock:

Adrenal cortical insufficiency induced by shock, or because of adrenal cortical insufficiency and the shock had no response to conventional therapy (hydrocortisone for commonly used drugs; if you do not want to have the mineralocorticoid activity, using methylprednisolone).

Hemorrhagic, traumatic, and surgical shock without response to conventional therapy. Although there is no perfect (double-blind) clinical research, but animal experiment data show possible methylprednisolone to conventional therapy (e.g., rehydration) invalid effective shock. See also section of "infectious shock" in "precautions".

5, Other:

Nervous system:

Brain edema caused by primary or metastatic tumor, and (or) surgery and radiotherapy; acute severe stage of multiple sclerosis; acute spinal cord injury. Treatment should begin within 8 hours after trauma.

- combined with appropriate antituberculous therapy for tuberculous meningitis with subarachnoid obstruction or occlusion.

- involving nerve or myocardial trichinelliasis.

- prevention of nausea and vomiting caused by cancer chemotherapy.

6, Endocrine disorders:

Primary or secondary adrenal insufficiency;

Acute adrenocortical insufficiency;

(the above disease hydrocortisone or hydrocortisone as the drug of choice, if necessary, can be combined with synthetic glucocorticoid and mineralocorticoid.)

Patients who are known to have or may have adrenal insufficiency are administered before surgery and with severe trauma or disease.

Congenital adrenal hyperplasia; non suppurative thyroiditis; cancer induced hypercalcemia.



Systemic fungal infection and known drug ingredient allergy disable.

Special risk population:

Take close medical supervision and should as far as possible to shorten the course of treatment should be to belong to the following special risk patients (see also the "notice" and "adverse effects"); children; diabetes; hypertension; mental disease; there are obvious symptoms of certain infectious diseases, such as tuberculosis or have obvious symptoms; some viral diseases, such as herpes zoster and spread to the eye.

[Pregnant and Lactating Momen Medication]

Some animal studies have shown that high doses of corticosteroids during pregnancy may cause fetal malformations.

Because did not study enough human reproduction, so when corticosteroids for pregnant and lactating women or women ready to give birth, should carefully weigh the benefits and the relationship between mother and embryo or fetus it to potential threats. Corticosteroids can be used only when needed. Discontinuation of the procedure must be performed gradually (see usage and dosage) if you have to discontinue the long-term use of corticosteroids during pregnancy (the same as other long-term treatments). However, the treatment of certain diseases, such as replacement therapy for adrenal cortical insufficiency, may require continued or even increased doses. Because corticosteroids are readily available through the placenta, babies born to mothers with high doses of corticosteroids during pregnancy should be carefully observed and evaluated for signs of adrenal cortical dysfunction.

Effects of methylprednisolone on childbirth is unknown.

Corticosteroid secretion with milk.

[Children Medication]

for a long period of time every day to give corticosteroids to inhibit the growth of children, this treatment can only be used for very serious situations. Infants and children may be reduced, depending on the severity of the disease and the patient's response, not on age and size. The total amount per 24 hours should not be less than 0.5mg/kg.


compliance with medication.


Store in a cool & dry place.

Protect from the light.

Keep out of the reach of the children.

[Validity period] Three years

Product Tags:

injection powder


dry powder injection

China Customized Inflatable Bumper Ball Game Bubble Adult Grass CE supplier

40mg Sterile Powder For Injection Methylprednisolone Sodium Succinate Injection I.M. / I.V. Use Images

Inquiry Cart 0
Send your message to this supplier
Enter your email please.
To: Wuhan uni-pharma bio-tech co.,ltd
Characters Remaining: (0/3000)
Inquiry Cart 0